Ureteral Stents Market 2023 | Size, Share, Growth, Trends And Forecast 2028

IMARC Group, a leading market research company, has released a report titled “Ureteral Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. According to the report, The global ureteral stents market size reached US$ 353.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 504.1 Million by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2023-2028.

Ureteral stents play a pivotal role in the field of urology as indispensable medical devices that are designed to treat and manage different urinary tract conditions. They are thin, flexible tubes made of biocompatible materials and inserted into the ureter to ensure unobstructed urine flow from the kidney to the bladder. It serves as a temporary pathway, facilitates bypassing obstructions that are caused by kidney stones, tumors, or strictures, and assists in alleviate pain and discomfort associated with urinary blockages. Ureteral stents are generally placed during surgical procedures, such as ureteroscopy or percutaneous nephrolithotomy, and they are left in the body of patients for a predetermined period until the underlying condition is resolved. As these stunts aid in maintaining urinary tract function, preventing kidney damage, and promoting postoperative recovery, the demand for ureteral stents is rising around the world.

Request for a sample copy of this report: https://www.imarcgroup.com/ureteral-stents-market/requestsample

Ureteral Stents Market Trends and Drivers:

The global ureteral stents market is experiencing stable growth on account of the rising prevalence of urological disorders, including kidney stones, urinary strictures, and tumors, the growing aging population, and changing lifestyle patterns and dietary habits. Besides this, numerous advancements in medical technology and surgical techniques are improving the placement and design of ureteral stents and consequently enhancing patient comfort and reducing complications. The launch of innovative stent materials like drug-eluting stents that prevents infection and tissue inflammation is also strengthening the growth of the market. Furthermore, the rising awareness about the benefits of ureteral stents in improving quality of life and minimizing the need for invasive surgical procedures is catalyzing the demand for ureteral stents.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product Type:

• Open End Stents

• Closed End Stents

• Double J-Stent

• Multiloop Stents

Breakup by Material:

• Metallic Ureteral Stents

• Polymer Ureteral Stents

  • Silicone Stents

  • Polyurethane Stents

  • Hybrid Stents

Breakup by Application:

• Kidney Stones

• Kidney Transplantation

• Tumors

• Urinary Incontinence

• Others

Breakup by End Use:

• Hospitals and Clinics

• Ambulatory Surgical Centers (ASCs)

• Others

Market Breakup by Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

Competitive Landscape with Key Player:

• Allium Medical Solutions Ltd.

• B. Braun Melsungen AG

• Biomerics

• Boston Scientific Corporation

• Becton

• Dickinson and Company

• Coloplast Ltd.

• Cook Group Incorporated

• Medline Industries Inc.

• Merit Medical Systems Inc.

• Olympus Corporation

• Teleflex Incorporated.

Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=3827&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal